/ world as we speak information/ GERD recommend to incorporate different preparations
VMRO insists on urgently offering the required portions of “Sputnik V”
The Council of Ministers to offer Bulgarian residents with entry to the Russian vaccine in opposition to COVID-19 “Sputnik V”. That is what the BSP insists within the draft choice, which the well being fee within the Nationwide Meeting will focus on at its assembly as we speak. GERB is categorical that Cornelia Ninova is attempting to make use of the Russian vaccine earlier than the election.
“Trud” sought members of the fee from completely different political forces to examine their attitudes earlier than voting on the mission.
“The Russian vaccine “Sputnik V” is sweet, and the proof is the truth that a number of European international locations determined to import it”, Dr. Kalin Popovski from VMRO commented to “Trud”. He clarified that they may request an modification to the BSP’s proposal, which might oblige the federal government to offer as rapidly as potential such portions of the Russian vaccine as would enable all Bulgarian residents who want to be immunized to have entry to the vaccine. Popovski defined that their proposal doesn’t contradict the Legislation on Medicinal Merchandise in Human Medication, for the reason that approved analog product of “Sputnik V” – AstraZeneca is in inadequate amount and the producer just isn’t fulfilling its contract.
“We are going to help a choice that can allow no vaccine that meets the necessities of the European Medicines Company to be excluded,” stated the Deputy Speaker of the Parliament and a member of the Well being Committee, Dr. Nigyar Jaffer from DPS.
The ruling GERB occasion is anticipated to submit a revised proposal that doesn’t exclude any vaccine exterior of these authorized by the EU. The situation is to have approval from the European Medicines Company. GERD is adamant that we can not import a vaccine that has an analogue authorized by the EC – specifically AstraZeneca. The managers consult with Artwork. 10 of the Legislation on Medicinal Merchandise in Human Medication. It reads as follows:
The Minister of Well being, on a reasoned proposal of the chief state well being inspector, in settlement with the chief director of the Govt Company for Medicines (EMA), could by order authorize therapy for a sure interval with a medicinal product that isn’t approved below Chapter Three, when within the nation has a declared epidemic brought on by pathogenic microorganisms or toxins, or there’s a suspected or confirmed unfold of chemical brokers or nuclear radiation and there’s no appropriate approved medicinal product.
In a report back to President Vladimir Putin of the Federal Company for Biomedicine
They launch an RNA-preparation “Mir – 19” and a brand new technology of immunizations
Drug for mobile immunity
Director of the Federal Company for Biomedicine in Russia, Veronika Skvortsova, reported to President Vladimir Putin a few new technology of preparations in opposition to COVID-19. Picture: Kremlin press service
In a number of days, mass scientific trials of a preparation in opposition to COVID-19, which was developed on the precept of microRNA – a small single-stranded and non-coding RNA molecule – will start in Russia. One of many detailed bulletins about it was made to the President of the Russian Federation, Vladimir Putin, by the director of the Federal Company for Biomedicine, Veronika Skvortsova. The drug is named “Mir-19” and in mid-March, scientists will start testing the second part of the drug. In response to Skvortsova, the molecule developed for “Mir-19” has no analogue on the planet, and the drug at the moment provides excellent outcomes in opposition to probably the most extreme types of the coronavirus, together with pneumonia.
In July, the Federal Company for Biomedicine can even be prepared for a brand new technology of vaccine, which won’t assault the S-protein of the coronavirus, however “different protein parts”, Skvortsova, quoted by the Kremlin press service, famous to the Russian President. In response to her, the brand new technology of vaccines, that are being labored on by the Federal Company for Biomedicine, won’t construct the so-called humoral immunity (based mostly on the manufacturing of antibodies), however will create mobile immunity. The latter can work between 13 and 17 years.
From Fb
The Russian embassy was flooded with inquiries
The Russian Embassy in Bulgaria has been inundated with inquiries from residents about find out how to get the Russian vaccine in opposition to COVID-19 “Sputnik V”. That’s the reason the mission revealed the next clarification on its Fb profile: “In reference to the quite a few questions relating to the Russian vaccine “Sputnik V”, we inform you that the embassy of the Russian Federation doesn’t have the vaccine, neither the Russian nor the the Bulgarian residents”.
The mission additionally specified that to ensure that “Sputnik V” to be imported into Bulgaria, it have to be authorized on the EU stage or by the Bulgarian drug regulator.
And the Czech Republic requested provides from Moscow
Hungary and Slovakia imported Sputnik V
Poland is investigating provides from China
On March 1, Serbia obtained one other 100,000 doses from “Sputnik V”, which are literally the second doses of the already delivered first 100,000. Belgrade additionally has a contract for the availability of the Chinese language vaccine in opposition to COVID-19.
Hungary was the primary nation within the EU to import the Russian vaccine “Sputnik V”. Prime Minister Viktor Orbán is profiting from a legislative alternative that permits EU international locations to obtain medicinal preparations that haven’t been authorized by the European Medicines Company, comparable to Sputnik V, in distinctive circumstances.
The federal government in Budapest motivated its choice with the delay in deliveries below the EU’s basic procurement program, which “leads to the lack of human lives”.
Hungary agreed to buy 2 million doses of the Russian vaccine (which is already in use within the nation), and in parallel additionally agreed to a different 5 million doses of the Chinese language “Sinopharm” vaccine.
Slovakia, second within the EU, ordered “Sputnik V” (2 million doses), with Prime Minister Igor Matovic explaining that it was “proper to purchase the Russian vaccine, as a result of COVID-19 doesn’t care about geopolitics”.
The Czech Republic additionally requested to purchase Sputnik V, however a contract with Moscow has not but been concluded.
Denmark, Austria and Poland additionally intend to hunt vaccines exterior the European Frequent Procurement Programme. Polish President Andrzej Duda expressed his nation’s curiosity in orders for Sinopharm’s preparation in a dialog together with his Chinese language counterpart Xi Jinping on Monday.
EU international locations have the liberty to provide themselves with different preparations at their very own threat
The European Medicines Company additionally approves Janssen
It’s developed on the precept of adenovirus
The European Medicines Company will focus on on March 11 the authorization to be used within the EU of the Janssen vaccine in opposition to COVID-19 of the pharmaceutical firms Johnson & Johnson.
The extraordinary assembly goals to achieve a choice on the identical day, it’s specified within the announcement, quoted by BTA. Earlier this week, the European Fee confirmed that the analysis of vaccines will likely be accelerated going ahead.
When authorized, Janssen’s vaccine will grow to be the fourth drug in opposition to the brand new illness to be authorized to be used within the EU. The EC signed contracts with six vaccine producers, specifying that EU international locations have the liberty to provide different preparations at their very own threat.
To this point, the Fee has granted 3 conditional advertising authorizations for vaccines developed by BioNTech and Pfizer, Moderna and AstraZeneca, after the European Medicines Company (EMA) gave a constructive evaluation of their security and efficacy.
What is understood for sure concerning the Janssen vaccine is that it’s based mostly on the identical adenovirus as AstraZeneca’s, however it’s a single-dose vaccine, not like all which have been given in two doses to this point. The agreed amount of doses for the EU of the Janssen vaccine is 400 million doses.
#Russian #vaccine #Sputnik #parliament
